Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. (Q52151974)

23 April 2018

title

Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. (English)

1 reference

23 April 2018

1 reference

1 reference

8

1 reference

23 April 2018

Johannes Rentzsch

object named as

Johannes Rentzsch

1

0 references

author name string

Ada Stadtmann

2

1 reference

23 April 2018

Christiane Montag

3

1 reference

23 April 2018

Hagen Kunte

4

1 reference

23 April 2018

Doris Plöckl

5

1 reference

23 April 2018

Rainer Hellweg

6

1 reference

23 April 2018

Jürgen Gallinat

7

1 reference

23 April 2018

Maria Christiane Jockers-Scherübl

9

1 reference

23 April 2018

publication date

17 July 2015

1 reference

23 April 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

23 April 2018

volume

266

1 reference

23 April 2018

issue

5

1 reference

23 April 2018

page(s)

409-421

1 reference

23 April 2018

https://scigraph.springernature.com/pub.10.1007/s00406-015-0616-y

exact match

0 references

cites work

The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

The endocannabinoid system as a target for modelling psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Medial temporal structures and memory functions in adolescents with heavy cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Altered brain tissue composition in heavy marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Abnormal cerebellar morphometry in abstinent adolescent marijuana users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis, cannabinoids and schizophrenia: integration of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neurophysiological effects of cannabinoids: implications for psychosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neurocognitive functioning and cannabis use in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis use disorders in schizophrenia: effects on cognition and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Influence of cannabis abuse on schizophrenic psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Meta-analysis of P300 and schizophrenia: patients, paradigms, and practical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

P300 and symptom improvement in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Novelty P3 and P3b in first-episode schizophrenia and chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Auditory-Evoked Potentials and Selective Attention: Different Ways of Information Processing in Cannabis Users and Controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Early and middle latency evoked potentials in medically and psychiatrically normal daily marihuana users: a paucity of significant findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis with high δ9-THC contents affects perception and visual selective attention acutely: an event-related potential study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Ethanol and marihuana effects on event-related potentials in a memory retrieval paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Updating P300: an integrative theory of P3a and P3b

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neurophysiological markers of novelty processing are modulated by COMT and DRD4 genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Categorization and validation of handedness using latent class analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neuropsychological performance in long-term cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

International consensus study of antipsychotic dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Naming norms for brief environmental sounds: effects of age and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Removing electroencephalographic artifacts by blind source separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Electromyogenic Artifacts and Electroencephalographic Inferences Revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Imaging human EEG dynamics using independent component analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

What is novel in the novelty oddball paradigm? Functional significance of the novelty P3 event-related potential as revealed by independent component analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Schizophrenia: the broken P300 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cognitive measures in long-term cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Neuropsychology and neuropharmacology of P3a and P3b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Contribution of human hippocampal region to novelty detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabinoid receptor localization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

The dual neuroprotective-neurotoxic profile of cannabinoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Heritability of cannabis initiation in Dutch adult twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Influences of parenting practices on the risk of having a chance to try cannabis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Multiple risk factor model predicting cannabis use and use disorders: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Childhood predictors of first chance to use and use of cannabis by young adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Symptoms of schizotypy precede cannabis use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0616-Y

Cannabis and motor function: fMRI changes following 28 days of discontinuation

21 January 2018

1 reference

12 December 2020

Delayed preattentional functioning in early psychosis patients with cannabis use

1 reference

12 December 2020

Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons

1 reference

12 December 2020

Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

The multiple selection vocabulary test (MSVT-B)--an accelerated intelligence test

1 reference

12 December 2020

Do cognitive impairments recover following cessation of cannabis use ?

1 reference

12 December 2020

Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects

1 reference

12 December 2020

Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

1 reference

12 December 2020

Elevated endogenous cannabinoids in schizophrenia

1 reference

12 December 2020

Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders.

1 reference

12 December 2020

Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample

1 reference

12 December 2020

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

12 December 2020

10.1007/S00406-015-0616-Y

Identifiers

DOI

1 reference

23 April 2018

PubMed ID

26182894

1 reference

23 April 2018